Anavex Life Sciences Corp (AVXL)
3.835
+0.08
(+1.99%)
USD |
NASDAQ |
May 03, 16:00
3.835
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Price: 3.835 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 02, 2024 | 3.73 | 3.77 | 3.625 | 3.76 | 741740.0 |
May 01, 2024 | 3.66 | 3.85 | 3.53 | 3.69 | 1.435M |
Apr 30, 2024 | 3.60 | 3.745 | 3.54 | 3.65 | 882438.0 |
Apr 29, 2024 | 3.42 | 3.745 | 3.41 | 3.65 | 1.162M |
Apr 26, 2024 | 3.40 | 3.48 | 3.37 | 3.44 | 949972.0 |
Apr 25, 2024 | 3.38 | 3.465 | 3.25 | 3.39 | 1.273M |
Apr 24, 2024 | 3.71 | 3.80 | 3.39 | 3.41 | 1.956M |
Apr 23, 2024 | 3.69 | 3.91 | 3.67 | 3.68 | 1.366M |
Apr 22, 2024 | 3.85 | 3.85 | 3.64 | 3.68 | 1.359M |
Apr 19, 2024 | 3.76 | 3.80 | 3.60 | 3.78 | 2.084M |
Apr 18, 2024 | 4.05 | 4.08 | 3.79 | 3.80 | 1.660M |
Apr 17, 2024 | 4.20 | 4.200 | 4.02 | 4.07 | 1.337M |
Apr 16, 2024 | 4.15 | 4.19 | 4.06 | 4.12 | 1.252M |
Apr 15, 2024 | 4.31 | 4.364 | 4.175 | 4.23 | 1.090M |
Apr 12, 2024 | 4.41 | 4.466 | 4.16 | 4.295 | 1.128M |
Apr 11, 2024 | 4.30 | 4.50 | 4.30 | 4.45 | 803845.0 |
Apr 10, 2024 | 4.23 | 4.295 | 4.17 | 4.29 | 1.412M |
Apr 09, 2024 | 4.40 | 4.445 | 4.29 | 4.39 | 975661.0 |
Apr 08, 2024 | 4.45 | 4.51 | 4.34 | 4.39 | 862071.0 |
Apr 05, 2024 | 4.45 | 4.52 | 4.34 | 4.42 | 1.116M |
Apr 04, 2024 | 4.69 | 4.702 | 4.46 | 4.48 | 1.525M |
Apr 03, 2024 | 4.52 | 4.76 | 4.455 | 4.62 | 1.077M |
Apr 02, 2024 | 4.85 | 4.865 | 4.515 | 4.54 | 1.470M |
Apr 01, 2024 | 5.08 | 5.08 | 4.875 | 5.02 | 819546.0 |
Mar 28, 2024 | 5.01 | 5.20 | 4.981 | 5.09 | 978032.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.22
Minimum
Aug 05 2019
28.86
Maximum
Jun 28 2021
8.627
Average
8.02
Median
Jul 25 2023
Price Benchmarks
Ventyx Biosciences Inc | 4.855 |
Checkpoint Therapeutics Inc | 1.58 |
Vertex Pharmaceuticals Inc | 401.11 |
Sarepta Therapeutics Inc | 133.68 |
NovaBay Pharmaceuticals Inc | 0.091 |
Price Related Metrics
Price to Book Value | 2.323 |
Earnings Yield | -14.34% |
Market Cap | 314.90M |